
Edit
TransThera | 药捷安康
http://www.transtherabio.com/Last activity: 18.02.2022
Probably Closed - Reference to 首页
TransThera Sciences (Nanjing), Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics to target diseases with major unmet medical needs via the internal research platform and open innovation. TransThera's current portfolio covers therapeutic areas such as oncology, cardiovascular, and inflammatory diseases.
Location: China, Fujian, Nanjing
Employees: 51-200
Founded date: 2016
Mentions in press and media 4
Date | Title | Description |
18.02.2022 | TransThera Announces that the IND Application of TT-01488, a Non-covalent Reversible BTK Inhibitor, for the Treatment of B-Cell Lymphomas has been Approved by the FDA in the US and Officially Accepted... | NANJING, China, Feb. 18, 2022 /PRNewswire/ -- TransThera Sciences (Nanjing), Inc. ("TransThera") announced that the U.S. Food and Drug Administration ("FDA") approved the Investigational New Drug ("IND") applic... |
03.11.2021 | TransThera Receives Fast Track Designation from FDA for its Core Product TT-00420 to Treat Cholangiocarcinoma | NANJING, China, Nov. 3, 2021 /PRNewswire/ -- TransThera Sciences (Nanjing) Inc., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative small molecule drug therapies for oncology, inflammatory and cardi... |
26.05.2021 | TransThera announces collaboration with Roche to evaluate TT-00420 as part of a novel combination to treat GI cancers in China | NANJING, China, May 26, 2021 /PRNewswire/ -- TransThera Biosciences Co. Ltd. ( "TransThera" ), a clinical stage biotechnology company dedicated to developing innovative therapeutics across oncology, cardiovascular, and inflammator... |
- | TransThera Biosciences | “Pharmaceutical Ankang (Nanjing) Technology Co., Ltd. is a family of innovative small molecule pharmaceutical research and development company in Jiangbei New District.Drug Jie Ankang in the study of new drugs covering swelling, immunity an... |